Epidemic MRSA clone ST22-IV is more resistant to multiple host- and environment-related stresses compared with

Rossella Baldan1, Paola Maria Vittoria Rancoita2, Clelia Di Serio2

  • 1Emerging Bacterial Pathogens Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-IV dominates hospitals due to superior stress resistance, not antibiotic resistance. This fitness advantage explains its epidemiological success and spread.

Area of Science:

  • Microbiology
  • Epidemiology
  • Infectious Diseases

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) clone ST22-IV is a dominant hospital-associated pathogen in Europe.
  • ST22-IV has demonstrated the ability to replace other MRSA clones within healthcare settings.
  • The relationship between MRSA clone success and environmental stress resistance remains understudied.

Purpose of the Study:

  • To investigate the fitness of MRSA clone ST22-IV compared to the replaced clone ST228-I.
  • To evaluate ST22-IV's resistance to various environmental and host-associated stresses.
  • To determine if enhanced stress survival contributes to the epidemiological success of ST22-IV.

Main Methods:

  • Comparative analysis of ST22-IV and ST228-I fitness.
  • Assessment of resistance to oxidative stress, high osmolarity, acidic/alkaline environments, desiccation, and heat shock.
  • Evaluation of autolytic activity, phenotypic characteristics, and the impact of antibiotic consumption.

Main Results:

  • ST22-IV dominance is not linked to increased antibiotic consumption or acquired resistances.
  • Virulence factors like α-haemolysin, β-haemolysin, and an active agr contribute to ST22-IV's pathogenicity.
  • ST22-IV exhibits significantly superior survival under all tested stress conditions compared to ST228-I.

Conclusions:

  • ST22-IV possesses a fitness advantage over ST228-I, facilitating its displacement.
  • This enhanced stress survival, rather than additional antibiotic resistance, explains ST22-IV's epidemic success.
  • The findings highlight the importance of environmental resilience in the spread of successful MRSA clones.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
172
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
118
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.7K